Centerpoint Advisory Group’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$546K Sell
4,463
-150
-3% -$17.2K 0.35% 61
2026
Q1
$506K Sell
4,613
-200
-4% -$22.7K 0.38% 52
2025
Q4
$548K Sell
4,813
-350
-7% -$39.7K 0.42% 55
2025
Q3
$566K Hold
5,163
0.44% 57
2025
Q2
$535K Hold
5,163
0.46% 55
2025
Q1
$535K Hold
5,163
0.53% 52
2024
Q4
$538K Buy
+5,163
New +$561K 0.52% 47

Other funds holding FXH

Centerpoint Advisory Group's FXH Position: Q2 2026 in Review

Centerpoint Advisory Group reduced its First Trust Health Care AlphaDEX Fund (FXH) stake by 3.3% in Q2 2026, selling an estimated $17.2K and leaving 4,463 shares worth $546K. The position accounts for 0.35% of the portfolio, ranked #61.

Centerpoint Advisory Group first reported a position in FXH in Q4 2024 and has held it in 7 quarters since. The position peaked at $566K in Q3 2025. 252 funds tracked by Wall St. Rank hold FXH as of Q2 2026.

  • Centerpoint Advisory Group held 4,463 shares of First Trust Health Care AlphaDEX Fund worth $546K as of Q2 2026.
  • Centerpoint Advisory Group sold 150 First Trust Health Care AlphaDEX Fund shares in Q2 2026, an estimated $17.2K.
  • First Trust Health Care AlphaDEX Fund made up 0.35% of Centerpoint Advisory Group's portfolio in Q2 2026, its #61 holding.
  • Centerpoint Advisory Group first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2024 and has held it in 7 quarters since.
  • Centerpoint Advisory Group's First Trust Health Care AlphaDEX Fund position peaked at $566K in Q3 2025.
  • 252 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q2 2026.

Based on Centerpoint Advisory Group's 13F filing for Q2 2026, filed 29 Jul 2026.